Carl Zeiss Meditec AGMEX:AFXN 68 PEG Ratio is 25.95 as of Jun. 24, 2026, which is 292% above its 10-year median of 6.62. GuruFocus rates MEX:AFXN with a GF Score™ of 68/100 and a GF Value™ of MXN8,900.18. The stock has 4 warning signs investors should review. Among 206 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks worse than 80.1% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Carl Zeiss Meditec AG's PEG Ratio or its related term are showing as below:
MEX:AFXN'
s PEG Ratio Range Over the Past 10 Years
Min: 1.08 Med: 6.62 Max: 84.19
Current: 4.68
During the past 13 years, Carl Zeiss Meditec AG's highest PEG Ratio was 84.19. The lowest was 1.08. And the median was 6.62.
MEX:AFXN's PEG Ratio is ranked worse than 80.1% of 206
companies
in the Medical Devices & Instruments industry
Industry Median: 1.95
vs MEX:AFXN: 4.68
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Carl Zeiss Meditec AG (MEX:AFXN) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Carl Zeiss Meditec AG (MEX:AFXN) has a PEG Ratio of 25.95 as of Jun. 24, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Carl Zeiss Meditec AG and its competitors. This is 292% above median its historical median of 6.62. Over the past decade, Carl Zeiss Meditec AG's PEG Ratio has ranged from 1.08 to 84.19. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #165 out of 206 companies in the Medical Devices & Instruments industry, placing it in the top 80.1%.
Is Carl Zeiss Meditec AG's PEG Ratio too high?
Carl Zeiss Meditec AG's current PEG Ratio of 25.95 is 292% above median its 10-year median of 6.62. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 84.19. The Medical Devices & Instruments industry median PEG Ratio is 1.95. Carl Zeiss Meditec AG's value of 25.95 is 1230.8% above this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #165 out of 206 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Carl Zeiss Meditec AG has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #165 out of 206 companies for PEG Ratio. This places Carl Zeiss Meditec AG in the lower half of its industry. The industry median PEG Ratio is 1.95. Carl Zeiss Meditec AG's value of 25.95 is 1230.8% above this benchmark. Historically, Carl Zeiss Meditec AG's own PEG Ratio has ranged from 1.08 to 84.19 over the past decade. While the company's 10-year median is 6.62 vs. the industry median of 1.95, Carl Zeiss Meditec AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.95, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current PEG Ratio of 25.95 is 1230.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current PEG Ratio is 25.95, which is 292% above median its own 10-year median of 6.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (MEX:AFXN) has a current PEG Ratio of 25.95. The stock's GF Value™ is MXN8,900.18, compared to a current price of MXN3,258.20 — trading 63.4% below its estimated fair value. The current PEG Ratio is 25.95, which is 292% above median its 10-year median of 6.62 and 1230.8% above the Medical Devices & Instruments industry median of 1.95. Carl Zeiss Meditec AG's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Carl Zeiss Meditec AG (MEX:AFXN), the current PEG Ratio is 25.95 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (MEX:AFXN) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of MXN3,258.20 is trading 63.4% below its estimated GF Value™ of MXN8,900.18.
Key valuation signals for MEX:AFXN:
PEG Ratio: 25.95 (292% above median its 10-year median of 6.62)
GF Value™: MXN8,900.18 vs. price of MXN3,258.20 (63.4% below fair value)
Industry Position: 1230.8% above the Medical Devices & Instruments median (#165 of 206)
No single metric tells the full story. See the MEX:AFXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
68GF Score
Get the complete analysis for MEX:AFXN
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AFXN has been successfully added to your 
